Mammary implant

• US 4,592,755 A
• Filed: 06/11/1985
• Issued: 06/03/1986
• Est. Priority Date: 06/11/1985
• Status: Expired due to Fees

• Current Assignee: Ethyl Corporation (Newmarket Corporation)
• Original Assignee: Ethyl Corporation (Newmarket Corporation)
• Inventors: Pettigrew, F. Alexander, Penton, Harold R., Kucsma, Michael E.
• Primary Examiner(s): McNeill, Gregory E.
• Application Number:
  US06/743,524
• Time in Patent Office: 357 Days
• Field of Search: 623/8, 128/462, 128/DIG. 21
• US Class Current: 623/8
• CPC Class Codes: A61F 2/12 Mammary prostheses and implants
• CPC Class Codes: A61L 27/18 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
• CPC Class Codes: C08L 85/02 containing phosphorus
• CPC Class Codes: Y10S 128/21 Silicone

Abstract

A prosthesis for subcutaneous implantation such as a mammary implant used in reconstructive surgery is made from a polyphosphazene elastomer (e.g. polyfluoroalkoxy phosphazene) sac containing a silicone gel. The sac is essentially impermeable to the silicone gel fill and overcomes a gel migration problem encountered with implants made using polysiloxane sacs.

Claims

1. An article of manufacture suitable for use as a body implant, said article comprising a supple liquid-impermeable sac defining a cavity, said cavity containing an inert stable liquid, said sac comprising a continuous film of a cured polyphosphazene elastomer composition.

2. An article of claim 1 wherein said polyphosphazene elastomer is a fluoroalkoxy-substituted polyphosphazene elastomer.

3. An article of claim 2 wherein said stable liquid comprises a polysiloxane oil, a polysiloxane gel or a mixture of both.

4. An article of claim 3 wherein said polyphosphazene composition comprises a blend of a fluoroalkoxy-substituted polyphosphazene and a filler.

5. An article of claim 3 wherein said fluoroalkoxy-substituted polyphosphazene is a cured polyphosphazene wherein the substituent groups comprise mainly a mixture of two or more different fluoroalkoxy groups having the structure --O--(CH₂)_n --(CF₂)_m --X wherein n is an integer from 1 to 3, m is an integer from 1 to 10 and X is hydrogen or fluorine.

6. An article of claim 5 wherein said substituent groups prior to cure include groups capable of chemical reaction to cross-link said fluoroalkoxy-substituted polyphosphazene.

7. An article of claim 6 wherein said groups capable of chemical reaction to cross-link are groups which contain olefinic unsaturation.

8. An article of claim 7 wherein said groups which contain olefinic unsaturation are selected from alkenoxy groups and alkenylaryloxy groups.

9. An article of claim 8 wherein said groups are allyloxy groups.

10. An article of claim 8 wherein said groups are o-allylphenoxy groups.

11. An article of claim 5 wherein said mixture of fluoroalkoxy groups comprises a mixture of trifluoroethoxy groups and one or more groups having the structure --O--(CH₂)_n --(CF₂)_p X wherein n is an integer having an average value of 1-3 and p is an integer having an average value of 2-7 and X is hydrogen or fluorine.

12. An article of claim 11 wherein said substituent groups prior to cure include groups capable of chemical reaction to cross-link said fluoroalkoxy-substituted polyphosphazene.

13. An article of claim 12 wherein said groups capable of chemical reaction to cross-link are groups which contain olefinic unsaturation.

14. An article of claim 13 wherein said groups which contain olefinic unsaturation are selected from alkenoxy groups and alkenylaryloxy groups.

15. An article of claim 14 wherein said groups are allyloxy groups.

16. An article of claim 14 wherein said groups are o-allylphenoxy groups.

17. An article of claim 3 wherein at least 10 mole percent of the substituent groups bonded to phosphorus are fluoroalkoxy groups and any remaining phosphorus substituent groups are selected from alkoxy, substituted alkoxy and up to 5 mole percent chloro groups.

18. An article of claim 1 wherein said polyphosphazene elastomer composition comprises a blend of a polyphosphazene and a polysiloxane.

19. An article of claim 18 wherein said polyphosphazene is a fluoroalkoxy-substituted polyphosphazene and said polysiloxane comprises dimethylsiloxane units, methylvinylsiloxane units, diphenylsiloxane units and/or methylphenylsiloxane units or mixtures of two or more of such siloxane units.

20. An article of claim 19 wherein said fluoroalkoxy-substituted polyphosphazene is substituted with a mixture of two or more different fluoroalkoxy groups having the structure --O--(CH₂)_n --(CF₂)_m --X wherein n is an integer from 1 to 3, m is an integer from 1 to 10 and X is hydrogen or fluorine.

21. An article of claim 20 wherein said fluoroalkoxy-substituted polyphosphazene contains, prior to cure, about 1-15 mole percent o-allylphenoxy groups.

22. A prosthesis for subcutaneous implantation in a patient having need for such implantation, said prosthesis comprising a leak-proof flexible sac containing a polysiloxane gel or oil, said sac comprising a continuous cured poly-fluoroalkoxy-substituted phosphazene elastomer wall which is substantially impermeable to said polysiloxane gel or oil.

23. A prosthesis of claim 22 wherein said poly-fluoroalkoxy-substituted phosphazene elastomer contains two or more different fluoroalkoxy substituents having the structure --O--(CH₂)_n --(CF₂)_m --X wherein n is an integer from 1 to 3, m is an integer from 1 to 10 and X is hydrogen or fluorine.

24. A prosthesis of claim 23 wherein said poly-fluoroalkoxy-substituted phosphazene is also substituted prior to cure with up to 15 mole percent of olefinically-unsaturated cross-linking groups.

25. A prosthesis of claim 24 wherein said cross-linking groups are o-allylphenoxy groups.

26. A prosthesis of claim 22 wherein said sac comprises a wall which comprises at least two continuous layers of flexible elastomer film, at least one of said layers comprising a cured poly-fluoroalkoxy-substituted phosphazene elastomer and at least one of said layers comprises a polysiloxane elastomer.

27. A prosthesis of claim 26 wherein said wall is a two-layer wall, the inner layer in contact with said silicone gel comprising a cured poly-fluoroalkoxy-substituted phosphazene elastomer and the outer layer comprising a cured polysiloxane elastomer.

28. An article of manufacture suitable for use as a liquid impermeable sac useful as a body implant for containing an inert stable liquid said article comprising a continuous membrane in the shape of said body implant forming a cavity, said membrane comprising a cured polyphosphazene elastomer composition.

29. An article of claim 28 wherein said polyphosphazene elastomer is a fluoroalkoxy-substituted polyphosphazene elastomer.

30. An article of claim 29 wherein said polyphosphazene composition comprises a blend of a fluoroalkoxy-substituted polyphosphazene and a filler.

31. An article of claim 29 wherein said fluoroalkoxy-substituted polyphosphazene is a cured polyphosphazene wherein the substituent groups comprise mainly a mixture of two or more different fluoroalkoxy groups having the structure --O--(CH₂)_n --(CF₂)_m --X wherein n is an integer from 1 to 3, m is an integer from 1 to 10 and X is hydrogen or fluorine.

32. An article of claim 31 wherein said substituent groups prior to cure include groups capable of chemical reaction to cross-link said fluoroalkoxy-substituted polyphosphazene.

33. An article of claim 32 wherein said substituent groups capable of chemical reaction to cross-link said fluoroalkoxy-substituted polyphosphazene are o-allylphenoxy groups.

34. An article of claim 33 including means for admitting an inert stable liquid into said cavity to form said body implant.